The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
- Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California
The purveyors of these myths, including politicians who have been soft peddling the impact of the coronavirus, aren’t doing the country any favors.
Republicans opposed Obamacare’s mandate as much as they decried any part of the bill. How would their replacement idea, pegged to incentives, work?
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in…
Contact Geoffrey for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
